ENGN — enGene Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $194.73m
- $4.31m
Annual cashflow statement for enGene Holdings, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -15.1 | -23.4 | -24.5 | -99.9 | -55.1 |
| Depreciation | |||||
| Non-Cash Items | 1.36 | 8.22 | 4.46 | 75.5 | 6.44 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.387 | -1.04 | 2.17 | -0.517 | 0.095 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -13.1 | -16 | -17.6 | -24.7 | -48.3 |
| Capital Expenditures | -0.192 | -0.248 | -0.153 | -0.318 | -0.925 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0.001 | 0 | — | -125 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.192 | -0.247 | -0.153 | -0.318 | -126 |
| Financing Cash Flow Items | -0.162 | -0.144 | -0.435 | 52.8 | 247 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 12.8 | 22.5 | 28 | 86.1 | 266 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.456 | 6.39 | 9.42 | 61.1 | 91.5 |